Podcast appearances and mentions of Matthew W Johnson

Dr Matthew Johnson is Professor of Psychiatry and Behavioral Sciences at Johns Hopkins, and one of the world's most published scientists on the human effects of psychedelics. His research focuses on the behavioural economics of drug use, addiction, and risk behaviour. In this conversation, we explore: — The underlying mechanisms which may help to explain why psychedelics are effective in treating a wide range of mental health problems — What happens in the brain during a psychedelic experience — The potential risks and who should avoid psychedelic medicines — Dr Johnson's advice for mental health professionals considering integrating psychedelic treatments in their practice. And more. You can follow Matt on X @Drug_Researcher. --- Dr. Matthew W. Johnson, is a distinguished Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University. He is internationally renowned for his prolific research on the human effects of psychedelics and his groundbreaking work in the behavioural economics of drug use, addiction, and risk behaviour. In 2008, Dr. Johnson published psychedelic safety guidelines, contributing to the resurgence of psychedelic research. He led groundbreaking studies on the psychedelic treatment of tobacco addiction and cancer distress, as well as investigating psilocybin for opioid dependence and PTSD. Dr. Johnson's research extends beyond psychedelics, with influential studies on various psychoactive substances. As President of the International Society for Research on Psychedelics and a respected NIH-funded Principal Investigator, he continues to be a leading figure in the field. Learn more at https://clinicalconnection.hopkinsmedicine.org/participant/matthew-johnson-phd. --- 3 Books Dr Johnson Recommends Every Therapist Should Read: — The Meaning of Addiction: An Unconventional View - Stanton Peele - https://amzn.to/3Q6GPF6 — Psychedelic Drugs Reconsidered - Lester Grinspoon and James B. Bakalar - https://amzn.to/3PLEwFX — Acid Dreams: The Complete Social History of LSD: The CIA, the Sixties, and Beyond - Martin A. Lee and Bruce Shlain - https://amzn.to/48O4FfZ

Matthew W. Johnson, PhD, is a senior researcher for the Center of Excellence for Psilocybin Research and Treatment at Sheppard Pratt's Institute for Advanced Diagnostics and Therapeutics. He is one of the world's most accomplished scientists on the human effects of psychedelics and has conducted seminal research in the behavioral economics of drug use, addiction, and risk behavior.  The conversation explores the evolution and impact of psychedelic research, particularly psilocybin and ketamine, over the past 20 years. Dr. Johnson highlights the shift from psilocybin's political casualty status to a multi-billion-dollar industry with FDA approval potential. Psilocybin shows promise in treating tobacco addiction, with a recent study doubling nicotine patch success rates. Ketamine, approved for depression, also shows potential in addiction treatment. The discussion touches on the therapeutic settings, the importance of preparation, and the potential for psychedelics to induce profound, lasting behavioral changes. The conversation also addresses the legal landscape, ethical considerations, and the risks associated with psychedelic use.0:00:00 - Intro0:00:13 - Interest in Psychedelics and Early Research0:03:09 - Behavioral Science & Psychedelics 0:05:20 - MK Ultra and Mind Manipulation 0:07:58 - Therapeutic Setting and Regulation 0:10:07 - Comparison with Traditional Treatments0:13:19 - Psychedelic Therapy Model0:16:45 - Music and Environment 0:18:44 - Personal Reactions and Screening0:23:15 - Neuroplasticity and Brain Changes0:30:27 - PTSD and MDMA0:33:15 - Ketamine & Addiction 0:51:20 - Realizations Under Psychedelics 0:56:20 - Prince Harry & Psychedelics 0:59:15 - Psychosis Risk & Vulnerability 1:03:05 - Pursuing Psychedelics Use & Legality 1:14:01 - Outro Dr. Matthew W. Johnson link:https://www.sheppardpratt.org/why-sheppard-pratt/our-experts/details/matthew-w-johnson-phd/Chuck Shute link tree: https://linktr.ee/chuck_shuteSupport the showThanks for Listening & Shute for the Moon!

This episode features leading researcher on therapeutic uses of psychedelics, Dr. Matthew W. Johnson of the Sheppard Pratt Institute for Advanced Diagnostics and Therapeutics. Dr. Johnson summarizes the current research on the potential benefits of psychedelics for treatment of depression, addiction, and other conditions; the known risks and benefits of such treatments; and Dr. Johson's important work on developing best practice guidance in relation to safety, risk assessment, and ethics in psychedelics research and treatment. We discuss recent developments in the U.S. Food and Drug Administration's (FDA) consideration of a request for approval of MDMA for treatment of post-traumatic stress disorder, the special problems the FDA faces in assessing psychedelics for possible therapeutic uses, and the dangers that continued unregulated uses of psychedelics pose in the absence of FDA approval and regulation. We end by hearing from Dr. Johnson about his future research plans.

Matthew W. Johnson, PhD, is a senior researcher for the Center of Excellence for Psilocybin Research and Treatment at Sheppard Pratt's Institute for Advanced Diagnostics and Therapeutics. He is one of the world's most accomplished scientists on the human effects of psychedelics and has conducted seminal research in the behavioral economics of drug use, addiction, and risk behavior. Dr. Johnson, an expert in behavioral pharmacology research, has decades of experience. In his most recent role, he served as a professor of psychiatry and behavioral sciences at Johns Hopkins Medicine. Dr. Johnson's current research centers around the efficacy and safety of psychedelics in the treatment of various medical and mental health conditions.  In 2008, Dr. Johnson played a crucial role in revitalizing human psychedelic research by publishing psychedelic risk and safety guidelines, which are now widely recognized as field standards. His trials have explored the effects of psychedelics on mystical experience, personality change, cancer distress treatment, and depression treatment. Dr. Johnson published the first research on psychedelic treatment for tobacco addiction in 2014. In 2021, he received the first federal grant in a half-century for treatment research with a classic psychedelic. He has received continuous National Institute of Health (NIH) funding as Principal Investigator since 2009 and has reviewed for >75 journals, including serving as guest editor on two special issues on psychedelics. Dr. Johnson has reviewed grants for the NIH, the National Science Foundation, the U.S. Military, and multiple governments outside the U.S. He was a member of the Addictions Risks and Mechanisms (ARM) NIH study section for 5 years. He has been invited to present his research in over a dozen countries. Dr. Johnson holds a Bachelor of Science degree from Eastern Oregon University and earned his PhD in Experimental Psychology from the University of Vermont. He served as President of the International Society for Research on Psychedelics in 2020, the first scientific society dedicated to quantitative research on psychedelics and one he played a role in founding. In 2019, Dr. Johnson also served as President of the Psychopharmacology and Substance Abuse Division of the American Psychological Association.  Dr. Johnson has been interviewed about psychedelics and other drugs by many newspapers, TV and radio programs, and podcasts around the world. These include interviews by Anderson Cooper on 60 Minutes, CNN, NPR, Fox News, Fox Business News, the BBC, The New York Times, The Washington Post, The Wall Street Journal, The Globe and Mail, The Atlantic, Newsweek, Vanity Fair, Marie Claire, Vogue, Washingtonian, Scientific American, Nature, the Lex Fridman Podcast, the Huberman Lab Podcast, Big Think, and by Michael Pollan in his best-selling book, How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence. Follow Dr. Johnson X: https://x.com/drug_researcher Website: https://www.sheppardpratt.org/why-sheppard-pratt/our-experts/details/matthew-w-johnson-phd/   The content of our show is educational only. It does not supplement or supersede your healthcare provider's professional relationship and direction. Always seek the advice of your physician or other qualified mental health providers with any questions you may have regarding a medical condition, substance use disorder, or mental health concern.

The real risks of psychedelics, explained by Johns Hopkins professor Dr. Matthew Johnson. A pattern emerges when you compare the harmfulness of different types of psychoactive drugs: alcohol and hard drugs like heroin and crack cocaine rank as the most harmful, while psychedelic substances like psilocybin and LSD score as the least harmful. It's perhaps not too surprising. After all, psychedelic substances are generally non-toxic and medically safe to consume. The drugs do not come with the same kind of overdose risks that substances like alcohol and heroin do. Still, psychedelics can have profound effects on the psyche. Bad trips are a real phenomenon. But bad trips are sometimes the result of an interplay between the drugs and the user's environment. As explained by Dr. Matthew W. Johnson, a professor of psychiatry and behavioral sciences at Johns Hopkins, the conditions under which someone experiences psychedelics can significantly influence the trip — for the worse or the better. About Matthew Johnson: Matthew W. Johnson, Ph.D., is The Susan Hill Ward Endowed Professor of Psychedelics and Consciousness Research at Johns Hopkins. Working with psychedelics since 2004, he is one of the world's most widely published experts on psychedelics. He has published research on psychedelics and mystical experience, personality change, tobacco smoking cessation, cancer distress treatment, and depression treatment. In 2021 he received as principal investigator the first grant in 50 years from the US government for a treatment study with a classic psychedelic, specifically psilocybin in treatment of tobacco addiction. He is also known for his expertise in behavioral economics, addiction, sexual risk behavior, and research with a wide variety of drug classes. He's been Interviewed by Anderson Cooper on 60 Minutes, the New York Times, the Washington Post, the Wall Street Journal, CNN, NPR, Fox News, Fox Business News, BBC and in Michael Pollan's book How to Change Your Mind. Learn more about your ad choices. Visit megaphone.fm/adchoices

Can psychedelics solve the ‘hard problem' of consciousness? Johns Hopkins professor Matthew Johnson explains. It seems safe to say that you have subjective experiences of what it's like to exist. But things get complicated when you try to prove that phenomenal experiences, or qualia, extend to every human being that you see around you. And things get even more complicated when you try to scientifically explain how the physical matter in your brain gives rise to consciousness, and why such experiences exist in the first place. This is known as the hard problem of consciousness. It has yet to be solved. Could the mind-altering power of psychedelics offer a solution to this longstanding problem? Dr. Matthew W. Johnson is leaving open the possibility. As a professor of psychiatry and behavioral sciences at Johns Hopkins, Dr. Johnson is one of the world's most published scientists when it comes to the effects of psychedelics on the human brain. In this Big Think interview, Dr. Johnson explains why we should be both open and careful about the prospect of psychedelics helping us crack the hard problem of consciousness, which remains one of the world's most puzzling questions. 0:00 Defining consciousness 0:47 The ‘hard problem' of consciousness 1:44 Psychedelics & consciousness About Matthew Johnson: Matthew W. Johnson, Ph.D., is The Susan Hill Ward Endowed Professor of Psychedelics and Consciousness Research at Johns Hopkins. Working with psychedelics since 2004, he is one of the world's most widely published experts on psychedelics. He has published research on psychedelics and mystical experience, personality change, tobacco smoking cessation, cancer distress treatment, and depression treatment. In 2021 he received as principal investigator the first grant in 50 years from the US government for a treatment study with a classic psychedelic, specifically psilocybin in treatment of tobacco addiction. He is also known for his expertise in behavioral economics, addiction, sexual risk behavior, and research with a wide variety of drug classes. He's been Interviewed by Anderson Cooper on 60 Minutes, the New York Times, the Washington Post, the Wall Street Journal, CNN, NPR, Fox News, Fox Business News, BBC and in Michael Pollan's book How to Change Your Mind. Learn more about your ad choices. Visit megaphone.fm/adchoices

To access our conference library of 200+ fascinating psychology talks and interviews (with certification), please visit: https://twumembers.com Professor Steven Hayes and Professor Matthew Johnson. Although they work in widely different fields, with Matt being a leading researcher in psychedelics at John Hopkins, and Steve being the co-developer of Acceptance and Commitment Therapy, both have reached similar conclusions about the psychological processes underneath mental health and wellbeing - so I thought it might be interesting to bring them together for this conversation. You'll learn: — How a behaviourist perspective has been advantageous for Matt and Steve in their research — How and why psychedelics may promote “psychological flexibility” — Steve and Matt's thoughts on the origins of spirituality — Their views on consciousness and the “hard problem”. And more. You can follow Matt on X @Drug_Researcher and learn more about Steven's work by going to https://stevenchayes.com. You can also check out the PsychFlex App by visiting: https://psychflex.com/signup. --- Steven C. Hayes, PhD, is a professor of psychology at the University of Nevada, Reno. The author of forty-three books and more than six hundred scientific articles, he has served as president of the Association for Behavioral and Cognitive Therapy and the Association for Contextual Behavioral Science and is one of the most cited psychologists in the world. Dr. Hayes initiated the development of Acceptance and Commitment Therapy (ACT) and of Relational Frame Theory (RFT), the approach to cognition on which ACT is based. Most recently, he has been focused on developing Process Based Therapy along with Prof Stefan Hofmann. Dr. Matthew W. Johnson, PhD, is a distinguished Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University. He is internationally renowned for his prolific research on the human effects of psychedelics and his groundbreaking work in the behavioral economics of drug use, addiction, and risk behavior. In 2008, Dr. Johnson published psychedelic safety guidelines, contributing to the resurgence of psychedelic research. He led groundbreaking studies on the psychedelic treatment of tobacco addiction and cancer distress, as well as investigating psilocybin for opioid dependence and PTSD. Dr. Johnson's research extends beyond psychedelics, with influential studies on various psychoactive substances. As President of the International Society for Research on Psychedelics and a respected NIH-funded Principal Investigator, he continues to be a leading figure in the field. Learn more at www.hopkinsmedicine.org/profiles/details/matthew-johnson. --- Interview Links: — Dr Hayes' website - https://stevenchayes.com/ — Dr Hayes' books - https://amzn.to/3MQlJbV — Dr Johnson's Profile - http://www.hopkinsmedicine.org/profiles/details/matthew-johnson — Dr Johnson's Twitter - https://twitter.com/drug_researcher?lang=en

How a ‘heroic dose' of psychedelics can be therapeutic, explained by a Johns Hopkins professor. Psychedelic research is enjoying a renaissance. Recent studies have shown that psychedelic drugs like LSD and psilocybin seem to be a safe and effective method for treating conditions like depression, anxiety, and post-traumatic stress disorder. And unlike common antidepressants, some people report long-lasting improvements in their mental health conditions after taking just one dose of psychedelics. What makes these substances so unique and powerful? That's one of the driving questions behind the research of Matthew W. Johnson, who has conducted numerous studies on the nature of addiction, psychedelics, and other psychoactive substances. Chapters: 0:00 Effing up the ineffable 1:56 Pioneers of psychedelic therapy 2:35 Psychedelics go underground 3:26 The psychedelic renaissance 4:50 Taking a ‘heroic dose' at Johns Hopkins 8:44 The challenges of psychedelic therapy 9:46 The mental health revolution --------------------------------------------------------------------- About Matthew Johnson: Matthew W. Johnson, Ph.D., is The Susan Hill Ward Endowed Professor of Psychedelics and Consciousness Research at Johns Hopkins. Working with psychedelics since 2004, he is one of the world's most widely published experts on psychedelics. He has published research on psychedelics and mystical experience, personality change, tobacco smoking cessation, cancer distress treatment, and depression treatment. In 2021 he received as principal investigator the first grant in 50 years from the US government for a treatment study with a classic psychedelic, specifically psilocybin in treatment of tobacco addiction. He is also known for his expertise in behavioral economics, addiction, sexual risk behavior, and research with a wide variety of drug classes. He's been Interviewed by Anderson Cooper on 60 Minutes, the New York Times, the Washington Post, the Wall Street Journal, CNN, NPR, Fox News, Fox Business News, BBC and in Michael Pollan's book How to Change Your Mind. --- Send in a voice message: https://podcasters.spotify.com/pod/show/bigthink/message Learn more about your ad choices. Visit megaphone.fm/adchoices

How do substances affect behavior, and how can we affect positive behavior change?If YOU want to quit a substance, can these compounds them?How do we give them the tools that make them more successful?This week, we sit down with Dr. Matthew Johnson to discuss the following:Micro, Recreational & Heroic Dose: How to think about themIs Micro-dosing just a placebo effectAddiction, Depression, Mental Health, and Other OpportunitiesA Must Listen to Rapid FireAbout  Dr. Matthew Johnson Dr. Matthew W. Johnson, Ph.D., is Professor of Psychiatry and Behavioral Sciences at Johns Hopkins. He is one of the world's most published scientists on the human effects of psychedelics, and has conducted seminal research in the behavioral economics of drug use, addiction, and risk behavior. Dr. Johnson earned his Ph.D. in experimental psychology at the University of Vermont in 2004.Guest Links:https://www.hopkinsmedicine.org/profiles/details/matthew-johnsonhttps://twitter.com/Drug_ResearcherFollow us: Our Links.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain The Dime is a top 5% most shared  global podcast The Dime is a top 50 Cannabis Podcast Sign up for our playbook here:

How do substances affect behavior, and how can we affect positive behavior change?If YOU want to quit a substance, can these compounds them?How do we give them the tools that make them more successful?This week, we sit down with Dr. Matthew Johnson to discuss the following:Micro, Recreational & Heroic Dose: How to think about themIs Micro-dosing just a placebo effectAddiction, Depression, Mental Health, and Other OpportunitiesA Must Listen to Rapid FireAbout  Dr. Matthew Johnson Dr. Matthew W. Johnson, Ph.D., is Professor of Psychiatry and Behavioral Sciences at Johns Hopkins. He is one of the world's most published scientists on the human effects of psychedelics, and has conducted seminal research in the behavioral economics of drug use, addiction, and risk behavior. Dr. Johnson earned his Ph.D. in experimental psychology at the University of Vermont in 2004.Guest Links:https://www.hopkinsmedicine.org/profiles/details/matthew-johnsonhttps://twitter.com/Drug_ResearcherFollow us: Our Links.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain The Dime is a top 5% most shared  global podcast The Dime is a top 50 Cannabis Podcast Sign up for our playbook here:

How do substances affect behavior, and how can we affect positive behavior change?If YOU want to quit a substance, can these compounds them?How do we give them the tools that make them more successful?This week, we sit down with Dr. Matthew Johnson to discuss the following:Micro, Recreational & Heroic Dose: How to think about themIs Micro-dosing just a placebo effectAddiction, Depression, Mental Health, and Other OpportunitiesA Must Listen to Rapid FireAbout  Dr. Matthew Johnson Dr. Matthew W. Johnson, Ph.D., is Professor of Psychiatry and Behavioral Sciences at Johns Hopkins. He is one of the world's most published scientists on the human effects of psychedelics, and has conducted seminal research in the behavioral economics of drug use, addiction, and risk behavior. Dr. Johnson earned his Ph.D. in experimental psychology at the University of Vermont in 2004.Guest Links:https://www.hopkinsmedicine.org/profiles/details/matthew-johnsonhttps://twitter.com/Drug_ResearcherFollow us: Our Links.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain The Dime is a top 5% most shared  global podcast The Dime is a top 50 Cannabis Podcast Sign up for our playbook here:

In this episode, Kyle interviews The Susan Hill Ward Endowed Professor of Psychedelics and Consciousness Research at Johns Hopkins, and renowned researcher of nearly 20 years: Matthew W. Johnson, Ph.D. Recorded in-person at MAPS' Psychedelic Science after running an 8-hour workshop on psychedelic therapy for addiction treatment, Johnson was still happy to sit down with PT to explore a wide range of topics: the under-researched concept of integration; how to best take advantage of optimal neuroplastic windows; why psycholytic therapy used to be more common; how our current protocols and research models are largely arbitrary; and his hopes for new, experimental, and flexible models of psychedelic therapy. He also discusses his ongoing smoking cessation studies; the Oregon model (are we doing therapy or not?); misrepresentation in psychedelic therapy and knowing your lane; and the role of music in psychedelics: why shouldn't people pick the music they know will give them goosebumps? Click here to head to the show notes page.

Dr. Matthew W. Johnson, Ph.D. joins Jillian this week. He's the Susan Hill Ward Endowed Professor of Psychedelics and Consciousness Research at Johns Hopkins and the world's most widely published expert on psychedelics. His research in the clinical use of psychedelics has helped people transform their lives. From quitting smoking to cancer distress treatment, management of anxiety, depression and more - psychedelics may change the future of psychology and behavioral science as we know it. First, we take a deep dive into the historical and cultural components of drugs like peyote, mescaline, ayahuasca, psylocibin, LSD, morning glory, and more. Then, Dr. Johnson explains how these drugs affect the brain and, subsequently, how they work to help us heal psychological trauma, overcome addiction, and find peace. Plus, listener questions for Dr. Johnson on everything from micro dosing to LSD for chronic pain management. This show will blow your mind! Find out how psychedelics might help you. Guest Links:Twitter: @Drug_ResearcherLinked In: https://www.linkedin.com/in/matthew-w-johnson-a400562/Instagram: https://www.instagram.com/drug_researcher/Website: https://www.hopkinsmedicine.org/profiles/details/matthew-johnsonFor 25% off The Fitness App by Jillian Michaels, go to www.thefitnessapp.com/podcastdealFollow us on Instagram @JillianMichaels and @MartiniCindyJillian Michaels Community: https://www.facebook.com/groups/1880466198675549Email your questions to JillianPodcast@gmail.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Matthew W. Johnson, Ph.D. joins Paul F. Austin to share his studies of psilocybin for smoking cessation, cancer distress treatment, and more In this episode, we feature another special interview recorded at the 2022 Wonderland conference in Miami, FL. Find episode links, summary, and transcript here. Matthew W. Johnson, Ph.D. is the Susan Hill Ward Endowed Professor of Psychedelics and Consciousness Research at Johns Hopkins. Working with psychedelics since 2004, he is one of the world's most widely published experts in the field. He has published research on psychedelics and mystical experience, personality change, tobacco smoking cessation, cancer distress treatment, and depression treatment. In 2021, as principal investigator, he received the first grant in 50 years from the US government for a treatment study with a classic psychedelic, specifically psilocybin in the treatment of tobacco addiction. He is also known for his expertise in behavioral economics, addiction, sexual risk behavior, and research with a wide variety of drug classes. Highlights: How Dr. Johnson's own life has changed as a result of his years of research, including psilocybin for the treatment of cancer distress. Dr. Johnson's study on psilocybin for smoking cessation; the first US government-funded study on the therapeutic use of a psychedelic in 50 years. The initial findings of psilocybin vs. nicotine patch as smoking-cessation treatments. How Dr. Johnson plans to contribute to psychedelic research and oversight as the industry grows. Dr. Johnson cautions psychedelic therapists against inappropriately pushing spiritual or religious frameworks onto patients. Episode Links: Dr. Johnson on Google Scholar Dr. Johnson on Twitter Dr. Johnson's smoking cessation study on ClinicalTrials.gov Dr. Johnson's paper, “Consciousness, Religion, and Gurus: Pitfalls of Psychedelic Medicine” Book, The Perennial Philosophy by Aldous Huxley Book, The Immortality Key by Brian Muraresku These show links may contain affiliate links. Third Wave receives a small percentage of the product price if you purchase through the above affiliate links. This episode is brought to you by Apollo Neuro, the first scientifically validated wearable that actively improves your body's resilience to stress. Apollo was developed by a friend of Third Wave, Dr. David Rabin M.D Ph.D., a neuroscientist and board-certified psychiatrist who has been studying the impact of chronic stress in humans for nearly 15 years. Third Wave listeners get 15% off—just use this link.

Link from the show:* Connect with Matthew on Twitter* Connect with Ryan on Twitter* Subscribe to the newsletterAbout my guest:Dr. Matthew W. Johnson, Ph.D., is Professor of Psychiatry and Behavioral Sciences at Johns Hopkins. He is one of the world's most published scientists on the human effects of psychedelics, and has conducted seminal research in the behavioral economics of drug use, addiction, and risk behavior. Dr. Johnson earned his Ph.D. in experimental psychology at the University of Vermont in 2004.Working with psychedelics for 16 years, Dr. Johnson published psychedelic safety guidelines in 2008, helping to resurrect psychedelic research. As Principle Investigator he developed and published the first research on psychedelic treatment of tobacco addiction in 2014. Dr. Johnson and colleagues published the largest study of psilocybin in treating cancer distress in 2016. His 2018 psilocybin abuse liability review recommended placement in Schedule-IV upon potential medical approval. He is Principle Investigator on funded studies investigating psilocybin in the treatment of opioid dependence and PTSD. Beyond psilocybin, in 2011 Dr. Johnson published the first-ever blinded human research showing psychoactive effects of salvinorin A, the active constituent in Salvia divinorum. He also published in 2017 the first data indicating that MDMA pill testing services may reduce harm, specifically by reducing drug consumption of unknown or undesired adulterants.Dr. Johnson is recognized for his research in behavioral economics, behavioral pharmacology, and behavior analysis. He has conducted seminal and widely cited research applying behavioral economic principles such as delay discounting and demand analysis to decision making within addiction, drug consumption, and risk behavior. This includes research determining delay discounting to be a fundamental behavioral process underlying addiction across drug classes, using economic demand analysis to determine the roles of nicotine and nonpharmacological factors in the abuse liability tobacco and other nicotine products, and using delay discounting, probability discounting, and demand analysis to understand sexual risk including condom non-use in casual sex situations. He conducted the first research administering cocaine to humans in determining that cocaine increases sexual desire and affects sexual decision making. He has conducted similar research administering methamphetamine and alcohol, examining effects on sexual decision making. He has published studies on drugs across nearly all psychoactive classes, including studies of cocaine, methamphetamine, tobacco/nicotine, alcohol, opioids, cannabis, benzodiazepines, psilocybin, dextromethorphan, salvinorin A, GHB, caffeine, and cathinone analogs compounds (so-called “bath salts”).Dr. Johnson was 2019 President of the Psychopharmacology and Substance Abuse Division of the American Psychological Association, and is current President of the International Society for Research on Psychedelics, an organization he founded with colleagues. He has received continuous NIH funding as Principal Investigator since 2009. He has reviewed for >75 journals and has served as guest editor on two special issues on psychedelics. Dr. Johnson has reviewed grants for NIH, NSF, the US Military, and multiple governments outside of the US. He is a standing member of the Addictions Risks and Mechanisms (ARM) NIH study section. He has provided invited presentations in 13 nations.Dr. Johnson has been interviewed widely by media about psychedelics and other drugs. These have included interviews by the New York Times, the Washington Post, the Wall Street Journal, the Globe and Mail, the Daily Mail, USA Today, the Chicago Tribune, the San Francisco Chronicle, the Denver Post, the Baltimore Sun, CNN, CBS News, NBC News, the Atlantic, Newsweek, Vanity Fair, Marie Claire, Vogue, Whole Living, the Washingtonian, Scientific American, Nature, Vice, Insider, Inverse, Healthline, and Psychology Today. Dr. Johnson has appeared for interviews on numerous television and radio shows including 60 Minutes, CNN's Wolf Blitzer Situation Room, Fox Business News' Kennedy, the Dr. Oz Show, PBS' Retro Report, Labyrint (television show in the Netherlands), Spectrum News NY1, the BBC World Service, NPR's Morning Edition, NPR's Kojo Nnamdi Show, New Zealand Radio, and Newstalk Radio Ireland. Dr. Johnson's panel discussion with Tim Ferriss at the Milken Institute Global Conference was broadcast on the Tim Ferriss Podcast. Dr. Johnson and his research were featured in an episode of Breakthrough on the National Geographic Channel, produced by Ron Howard, and in Michael Pollan's best-selling book, How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence. Get full access to Dispatches from the War Room at dispatchesfromthewarroom.substack.com/subscribe

Where would we be if psychedelic research was never halted? We'll never be able to answer that question, but the exciting thing is that we are currently living through the renaissance of psychedelic science, and today's podcast is with one of the leading experts of this movement. Dr. Matthew W. Johnson, Ph.D., is a Professor of Psychiatry and Behavioral Sciences at Johns Hopkins. He is one of the world's most published scientists on the human effects of psychedelics, and is on the front line of resurrecting psychedelic research. In today's episode, we dive into the current state of psychedelic research, and we posit potential upcoming applications for a variety of psychedelic compounds (DMT, Psilocybin, MDMA, Ketamine, etc.). More generally, this discussion was a beautiful merger between my experiential knowledge and Dr. Matthew Johnson's scientific findings. He is someone who I admire for his curious attitude (true to the original understanding of science) towards topics that most people dismiss. Connect with Matthew Johnson Ph.D Twitter | https://twitter.com/drug_researcher This episode is sponsored by: ONNIT Get 10% off all Onnit Products: https://bit.ly/3LMVArK Helix Sleep save up to 200 dollars off all mattress orders AND two free pillows by visiting HelixSleep.com/AMP FOUR VISIONS MARKET spiritual tools & art. Visit fourvisionsmarket.com And enter the code AMP for 15% off your first order. To partner with the Aubrey Marcus Podcast Connect with Aubrey Website | https://www.aubreymarcus.com/ Instagram | https://www.instagram.com/aubreymarcus/ Twitter | https://twitter.com/aubreymarcus Facebook | https://www.facebook.com/AubreyMarcus/ YouTube | https://bit.ly/2DLctpk Check out Own The Day Own Your Life by Aubrey Marcus| https://bit.ly/2t6x4hu Subscribe to the Aubrey Marcus Newsletter: https://www.aubreymarcus.com/pages/email Join the Aubrey Marcus Podcast Premium Membership on Supercast and get all the new AMP episodes ad free, a monthly AMA episode only for the Supercast community, as well as exclusive content only found on the Aubrey Marcus Premium Subscription like guided meditations, breathworks and unreleased podcast episodes | https://aubreymarcuspodcast.supercast.com/ Subscribe to the Aubrey Marcus Podcast: iTunes | https://apple.co/2lMZRCn Spotify | https://spoti.fi/2EaELZO Stitcher | https://bit.ly/2G8ccJt IHeartRadio | https://ihr.fm/3CiV4x3 Google Podcasts | https://bit.ly/3nzCJEh Android | https://bit.ly/2OQeBQg

Today, you'll learn about some new, emerging data that is giving us surprising insight into human metabolism, how magic mushrooms are on the forefront of mental health treatment and new jet technology that could get us anywhere in the world in under two hours.True or False: your metabolism slows as you age. The answer isn't what you think! “Burn, baby, burn: the new science of metabolism” by David Coxhttps://www.theguardian.com/science/2021/oct/30/burn-baby-burn-the-new-science-of-metabolism“Surprising findings about metabolism and age” by Fatima Cody Stanford, MD, MPH, MPA, FAAP, FACP, FTOS and Chika Anekwe, MD, MPHhttps://www.health.harvard.edu/blog/surprising-findings-about-metabolism-and-age-202110082613“Middle-age spread isn't down to metabolism, but we know how to beat it” by Sara Novakhttps://www.newscientist.com/article/mg25333774-900-middle-age-spread-isnt-down-to-metabolism-but-we-know-how-to-beat-it/“3 lifestyle changes that can boost your metabolism and prevent weight gain” by Brianna Steinhilberhttps://www.today.com/health/diet-fitness/boost-metabolism-prevent-weight-gain-rcna19394Mushrooms are more magical than fueling your next trip - they could help treat depression. “Psilocybin treatment for major depression effective for up to a year for most patients, study shows” by Marisol Martinezhttps://hub.jhu.edu/2022/02/16/psilocybin-relieves-depression-for-up-to-a-year/“Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up” by Natalie Gukasyan, Alan K Davis, Frederick S Barrett, Mary P Cosimano, Nathan D Sepeda, Matthew W Johnson, and Roland R Griffithshttps://journals.sagepub.com/doi/10.1177/02698811211073759“Psychoactive ingredient in 'magic' mushrooms may treat depression for much longer than traditional antidepressants when combined with therapy, study backed by Tim Ferriss finds” by Dr. Catherine Schuster-Brucehttps://www.businessinsider.com/magic-mushroom-depression-mental-health-treatment-psilocybin-therapy-tim-ferriss-2022-2“Can psychedelics meet their potential for treating mental health disorders?” by Laura Sandershttps://www.sciencenews.org/article/psychedelic-drugs-treatment-mental-health-disorders-depression“Decriminalizing 'magic mushrooms'? Rhode Island lawmakers are considering it. Here's why:” by Patrick Andersonhttps://www.providencejournal.com/story/news/politics/2022/03/08/rhode-island-considering-decriminalizing-magic-psilocybin-mushrooms/9412817002/Getting anywhere in the world in 2 hours may not be the stuff of science fiction for much longer! "The Experimental Engine That Could Get Us Anywhere in the World in 2 Hours" by Caroline Delberthttps://www.popularmechanics.com/science/a34840801/sodramjet-engine-hypersonic-flight-test/“Chinese team test jet engine ‘able to reach anywhere on Earth within 2 hours'” by Stephen Chenhttps://www.scmp.com/news/china/science/article/3111985/chinese-team-test-jet-engine-able-reach-anywhere-earth-within-2“China Tests Hypersonic Jet Engine That Can Go 16 Times the Speed of Sound” by  Fabienne Langhttps://interestingengineering.com/china-tests-hypersonic-jet-engine-that-can-go-16-times-the-speed-of-sound“Scientists Test Hypersonic Jet Engine Prototype That Could Travel Anywhere On Earth In 2 Hours” by Jack Dunhillhttps://www.iflscience.com/technology/scientists-test-hypersonic-jet-engine-prototype-that-could-travel-anywhere-on-earth-in-2-hours/“How Does a Jet Engine Work” by NASAhttps://www.grc.nasa.gov/WWW/K-12/UEET/StudentSite/engines.html“Aircraft Propeller Basics” by Southern Wingshttps://www.southernwings.co.nz/aircraft-propeller-basics/“Keeping the SR-71 Blackbird (the World's First Stealth Plane) Secret Was Near Impossible” by Robert Beckhusenhttps://nationalinterest.org/blog/the-buzz/keeping-the-sr-71-blackbird-the-worlds-first-stealth-plane-17936“SR-71 Blackbird: Stories, Tales, and Legends” by Richard H. Grahamhttps://books.google.com/books?id=ZHkAJAq-2HQC&lpg=PA223&ots=9AS2-nsLCs&dq=limits%20on%20General%20staff%20on%20one%20flight&pg=PA223#v=snippet&q=record&f=falseFollow Curiosity Daily on your favorite podcast app to get smarter with Calli and Nate — for free! Still curious? Get exclusive science shows, nature documentaries, and more real-life entertainment on discovery+! Go to https://discoveryplus.com/curiosity to start your 7-day free trial. discovery+ is currently only available for US subscribers.

Today, you'll learn about the real science behind the five second rule and why you may wanna reconsider eating that candy off the ground, why researchers are looking to our furry friends to build better early warning systems for natural disasters, and why the first animal to ever fly had a real issue keeping its lunch down.Drop a french fry? Maybe just leave it there. 5-second rule: Science debunks food myth that stretches back to Gengis Khan by Sarah Wellshttps://www.inverse.com/science/five-second-rule-myth-debunkThe Science Behind The Five-Second Rule by Paul Dawson and Brian Sheldonhttps://www.sciencefriday.com/articles/the-science-behind-the-five-second-rule/Still Good? 5-Second Rule a Myth, Study Finds by Rachael Rettnerhttps://www.livescience.com/56158-5-second-rule-myth.htmlDouble Dipping? 5-Second Rule? Scientists Separate Food Fact From Fiction In New Book by Robin Younghttps://www.wbur.org/hereandnow/2018/11/16/double-dipping-5-second-rule-food-safetyWhat are your pets trying to tell you? Maybe there's an earthquake incoming. The animals that detect disasters by Norman Millerhttps://www.bbc.com/future/article/20220211-the-animals-that-predict-disastersCan Birds Tip Us Off to Natural Disasters? by Jason Gregghttps://www.smithsonianmag.com/science-nature/can-birds-tip-us-natural-disasters-180978571/Can animals sense when an earthquake is about to happen? by Anne Quainhttps://phys.org/news/2021-09-animals-earthquake.htmlBirds sensed severe storms and fled before tornado outbreak adapted from Cell Press publishing, article authored by Henry M Streby et alhttps://www.sciencedaily.com/releases/2014/12/141218131413.htmCell Press published articlehttps://www.cell.com/current-biology/fulltext/S0960-9822(14)01428-6Earthquake Warning Systems by Wikipediahttps://en.wikipedia.org/wiki/Earthquake_warning_systemNature of Pre-Earthquake Phenomena and their Effects on Living Organisms by Friedemann Freund and Viktor Stolchttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494396/Predicting the unpredictable; evidence of pre-seismic anticipatory behaviour in the common toad by Rachel Granthttps://www.researchgate.net/publication/227651706_Predicting_the_unpredictable_evidence_of_pre-seismic_anticipatory_behaviour_in_the_common_toadClues to how birds migrate using Earth's magnetic field by Helen Briggshttps://www.bbc.com/news/science-environment-57582451What do the first flying dinosaurs have in common with owls? Pellets. Fossils reveal that pterosaurs puked pellets by Carolyn Gramlinghttps://www.sciencenews.org/article/pterosaur-fossils-puke-pellet-regurgitation-foodYou may have missed… by Imma Perfettohttps://cosmosmagazine.com/health/you-may-have-missed-30/Like Owls, Some Prehistoric Flying Reptiles May Have Regurgitated Pellets by Margaret Osbornehttps://www.smithsonianmag.com/smart-news/like-owls-some-pterosaurs-may-have-regurgitated-pellets-180979551/What Is a Pterosaur? by American Museum of Natural Historyhttps://www.amnh.org/exhibitions/pterosaurs-flight-in-the-age-of-dinosaurs/what-is-a-pterosaurFollow Curiosity Daily on your favorite podcast app to get smarter with Calli and Nate — for free! Still curious? Get exclusive science shows, nature documentaries, and more real-life entertainment on discovery+! Go to https://discoveryplus.com/curiosity to start your 7-day free trial. discovery+ is currently only available for US subscribers.Midroll Ad Stamp: 9:34Episode 14Title: Burn Them Cals, Magic of Mushrooms, Flying at Mach 16Description: Today, you'll learn about some new, emerging data that is giving us surprising insight into human metabolism, how magic mushrooms are on the forefront of mental health treatment and new jet technology that could get us anywhere in the world in under two hours.True or False: your metabolism slows as you age. The answer isn't what you think! “Burn, baby, burn: the new science of metabolism” by David Coxhttps://www.theguardian.com/science/2021/oct/30/burn-baby-burn-the-new-science-of-metabolism“Surprising findings about metabolism and age” by Fatima Cody Stanford, MD, MPH, MPA, FAAP, FACP, FTOS and Chika Anekwe, MD, MPHhttps://www.health.harvard.edu/blog/surprising-findings-about-metabolism-and-age-202110082613“Middle-age spread isn't down to metabolism, but we know how to beat it” by Sara Novakhttps://www.newscientist.com/article/mg25333774-900-middle-age-spread-isnt-down-to-metabolism-but-we-know-how-to-beat-it/“3 lifestyle changes that can boost your metabolism and prevent weight gain” by Brianna Steinhilberhttps://www.today.com/health/diet-fitness/boost-metabolism-prevent-weight-gain-rcna19394Mushrooms are more magical than fueling your next trip - they could help treat depression. “Psilocybin treatment for major depression effective for up to a year for most patients, study shows” by Marisol Martinezhttps://hub.jhu.edu/2022/02/16/psilocybin-relieves-depression-for-up-to-a-year/“Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up” by Natalie Gukasyan, Alan K Davis, Frederick S Barrett, Mary P Cosimano, Nathan D Sepeda, Matthew W Johnson, and Roland R Griffithshttps://journals.sagepub.com/doi/10.1177/02698811211073759“Psychoactive ingredient in 'magic' mushrooms may treat depression for much longer than traditional antidepressants when combined with therapy, study backed by Tim Ferriss finds” by Dr. Catherine Schuster-Brucehttps://www.businessinsider.com/magic-mushroom-depression-mental-health-treatment-psilocybin-therapy-tim-ferriss-2022-2“Can psychedelics meet their potential for treating mental health disorders?” by Laura Sandershttps://www.sciencenews.org/article/psychedelic-drugs-treatment-mental-health-disorders-depression“Decriminalizing 'magic mushrooms'? Rhode Island lawmakers are considering it. Here's why:” by Patrick Andersonhttps://www.providencejournal.com/story/news/politics/2022/03/08/rhode-island-considering-decriminalizing-magic-psilocybin-mushrooms/9412817002/Getting anywhere in the world in 2 hours may not be the stuff of science fiction for much longer! "The Experimental Engine That Could Get Us Anywhere in the World in 2 Hours" by Caroline Delberthttps://www.popularmechanics.com/science/a34840801/sodramjet-engine-hypersonic-flight-test/“Chinese team test jet engine ‘able to reach anywhere on Earth within 2 hours'” by Stephen Chenhttps://www.scmp.com/news/china/science/article/3111985/chinese-team-test-jet-engine-able-reach-anywhere-earth-within-2“China Tests Hypersonic Jet Engine That Can Go 16 Times the Speed of Sound” by  Fabienne Langhttps://interestingengineering.com/china-tests-hypersonic-jet-engine-that-can-go-16-times-the-speed-of-sound“Scientists Test Hypersonic Jet Engine Prototype That Could Travel Anywhere On Earth In 2 Hours” by Jack Dunhillhttps://www.iflscience.com/technology/scientists-test-hypersonic-jet-engine-prototype-that-could-travel-anywhere-on-earth-in-2-hours/“How Does a Jet Engine Work” by NASAhttps://www.grc.nasa.gov/WWW/K-12/UEET/StudentSite/engines.html“Aircraft Propeller Basics” by Southern Wingshttps://www.southernwings.co.nz/aircraft-propeller-basics/“Keeping the SR-71 Blackbird (the World's First Stealth Plane) Secret Was Near Impossible” by Robert Beckhusenhttps://nationalinterest.org/blog/the-buzz/keeping-the-sr-71-blackbird-the-worlds-first-stealth-plane-17936“SR-71 Blackbird: Stories, Tales, and Legends” by Richard H. Grahamhttps://books.google.com/books?id=ZHkAJAq-2HQC&lpg=PA223&ots=9AS2-nsLCs&dq=limits%20on%20General%20staff%20on%20one%20flight&pg=PA223#v=snippet&q=record&f=falseFollow Curiosity Daily on your favorite podcast app to get smarter with Calli and Nate — for free! Still curious? Get exclusive science shows, nature documentaries, and more real-life entertainment on discovery+! Go to https://discoveryplus.com/curiosity to start your 7-day free trial. discovery+ is currently only available for US subscribers.

In this episode of The Session, psychedelics researcher Dr Matthew W. Johnson joins Tom Swarbrick to talk about how and why attitudes towards drugs' medicinal benefits are changing.

Stigma around psychedelics appears to be fading in this country. Interest in evidence-based ways to enhance treatment is on the rise - including research into the potential found by adding psilocybin–otherwise known as magic mushrooms–as well as MDMA, Ketamine, LSD, and Ayahuasca, especially with the expansion of mental health needs brought on by the pandemic. Studies are showing exciting results about the possibility for psychedelics to help people with treatment-resistant mental health disorders, including chronic depression, Post Traumatic Stress Disorder (PTSD) and substance use disorder.   “This is what makes psychedelics unique as potential medicines: they sort of open a window of opportunity, and we know biologically, there seems to be more mental flexibility. And based on animal research more–what we call–neuroplasticity.” - Dr. Matthew W. Johnson, Ph.D.   But there is still much to learn about what these medications do, how they work, how to administer them safely, and how to mitigate the risks they may pose, especially as recreational use of psychedelics may increase as a side-effect of their increasing visibility.    Our guest, Dr. Matthew W. Johnson, is the Susan Hill Ward Professor in Psychedelics and Consciousness, and Professor of Psychiatry and Behavioral Sciences at Johns Hopkins. He is one of the world's most published scientists on the human effects of psychedelics, and has conducted seminal research in the behavioral economics of substance use , and risk behavior.    If you enjoy this podcast, be sure to follow or subscribe wherever you are listening, and share the show with your colleagues and friends. You can also subscribe to our YouTube Channel here, https://www.youtube.com/c/PsychHub.   Future Of Mental Health is a Psych Hub Podcast and is for educational purposes only. Visit https://psychhub.com to dig deeper and access the world's most comprehensive platform for behavioral health education.   Follow us on Social Media Twitter: https://twitter.com/FOMHshow Instagram: https://www.instagram.com/psychhubeducation  YouTube: https://www.youtube.com/c/PsychHub 

welcome to the nonlinear library, where we use text-to-speech software to convert the best writing from the rationalist and ea communities into audio. this is: AMA: Tim Ferriss, Michael Pollan, and Dr. Matthew W. Johnson on psychedelics research and philanthropy, published by Aaron Gertler on the effective altruism forum. We're excited to bring you an AMA with three people who have done a lot to increase the profile and prospects of psychedelic research. Effective altruism has a history of engaging with psychedelics (see these posts, for example) as a promising intervention for mental health issues — one which could sharply reduce the suffering of tens or hundreds of millions of people. Between Tim, Michael, and Matt, we have many kinds of expertise here — nonprofit investing, journalism, medicine, and more. We hope the discussion is interesting, and useful for anyone who's thought about working or giving within this area. We'll gather questions for a couple of days. Michael and Matt will answer questions on Sunday, May 16th. Tim will answer questions on Tuesday, May 18th (we've pushed his original date back by one day). Author introductions Tim Ferriss Hi, everyone! I'm Tim Ferriss, and I'll be doing an AMA here. More on me: I'm an author (The 4-Hour Workweek, Tools of Titans, etc.) and early-stage investor (Uber, Shopify, Duolingo, Alibaba, etc.). Through my foundation and since circa 2015, I have committed at least $4-6 million to non-profit scientific research and clinical treatments of “intractable” psychiatric conditions such as treatment-resistant depression, opioid/opiate addiction, post-traumatic stress disorder (PTSD), and others. I believe (A) this research has the potential to revolutionize the treatment of mental health and addiction, which the data from studies thus far seem to support, and (B) I'm a case study. Psychedelics have saved my life several times over, including helping me to heal from childhood abuse. Projects and institutions include the Centre for Psychedelic Research at Imperial College London (the first such center in the world); the Center for Psychedelic and Consciousness Research at Johns Hopkins University School of Medicine (the first such center in the US); MAPS (Phase 3 studies for MDMA-assisted psychotherapy); divisions and studies at UCSF (e.g., The Neuroscape Psychedelic Division); The University of Auckland (LSD microdosing); and others (e.g., pro bono launch of Trip of Compassion documentary on MDMA-assisted psychotherapy). I evaluate non-profit and scientific initiatives in the same way I evaluate for-profit startups, and I believe some bets in this nascent field represent high-leverage, low-cost opportunities to bend the arc of history, much as Katharine McCormick did for the first birth control pill. Here is one blog post with more elaboration. I am happy to answer any questions through the AMA. Dr. Matthew Johnson is no doubt better qualified to answer the scientific (and more), and Michael Pollan is no doubt more qualified to answer the journalistic (and more), but I will do my best to be helpful! Michael Pollan I'm a journalist and author who focuses on ways that the human and natural worlds intersect — including within our minds. In 2015, I wrote a New Yorker article on psychotherapy, "The Trip Treatment", which profiled a number of cancer patients whose experiences with psilocybin had reduced or entirely banished their fear of death. This led me to embark on a two-year journey into the history of psychedelic policy and its potential for modern medicine, and to write a book: How to Change Your Mind: The New Science of Psychedelics. My forthcoming book, This is Your Mind on Plants, covers the strange contrast between the human experience with several plant drugs — opium, caffeine, and mescaline — and how we choose to define and regulate them. I'd be glad to answer questions about anything I've written on the subject. Particular topics of interest: The history of drug regulatio...

Coming in hot with two reality show pitches about dogs: "Romance or Rescue" and "The Right Pooch." Allison's is a wholesome affair, while Gaby's...not so much. The duo then answer a listener's question about how to forgive themself for their drunk behavior now that they are sober and have made amends. They're then joined by an extremely exciting guest, Matthew W. Johnson, a researcher on the forefront of the use of psychedelics for medical and mental health treatment. Are psychedelics the future of mental health treatment??? MAYBE! And finally, brand deals. Why we take what we take and don't take what we don't. And why people are mad either way!  Transcription: https://docs.google.com/document/d/1gGn0Mkim64M3DxZJxXnzvaxA90BfU1ivFlDxPykgxPk/edit?usp=sharing This has been a Forever Dog production  Produced by Melisa D. Monts Executive produced by Brett Boham, Joe Cilio and Alex Ramsey To listen to this podcast ad-free  Sign up for Forever Dog Plus at foreverdogpodcasts.com/plus Check out video clips of our podcasts on Youtube at youtube.com/foreverdogteam And make sure to follow us on Twitter, instagram and Facebook at ForeverDogTeam to keep up with all of the latest Forever Dog NewsSupport this podcast at — https://redcircle.com/just-between-us/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Coming in hot with two reality show pitches about dogs: "Romance or Rescue" and "The Right Pooch." Allison's is a wholesome affair, while Gaby's...not so much. The duo then answer a listener's question about how to forgive themself for their drunk behavior now that they are sober and have made amends. They're then joined by an extremely exciting guest, Matthew W. Johnson, a researcher on the forefront of the use of psychedelics for medical and mental health treatment. Are psychedelics the future of mental health treatment??? MAYBE! And finally, brand deals. Why we take what we take and don't take what we don't. And why people are mad either way!  This has been a Forever Dog production  Produced by Melisa D. Monts Executive produced by Brett Boham, Joe Cilio and Alex Ramsey To listen to this podcast ad-free  Sign up for Forever Dog Plus at foreverdogpodcasts.com/plus Check out video clips of our podcasts on Youtube at youtube.com/foreverdogteam And make sure to follow us on Twitter, instagram and Facebook at ForeverDogTeam to keep up with all of the latest Forever Dog News

Coming in hot with two reality show pitches about dogs: "Romance or Rescue" and "The Right Pooch." Allison's is a wholesome affair, while Gaby's...not so much. The duo then answer a listener's question about how to forgive themself for their drunk behavior now that they are sober and have made amends. They're then joined by an extremely exciting guest, Matthew W. Johnson, a researcher on the forefront of the use of psychedelics for medical and mental health treatment. Are psychedelics the future of mental health treatment??? MAYBE! And finally, brand deals. Why we take what we take and don't take what we don't. And why people are mad either way! This has been a Forever Dog production Produced by Melisa D. MontsExecutive produced by Brett Boham, Joe Cilio and Alex RamseyTo listen to this podcast ad-free Sign up for Forever Dog Plus at foreverdogpodcasts.com/plusCheck out video clips of our podcasts on Youtube at youtube.com/foreverdogteamAnd make sure to follow us on Twitter, instagramSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Matthew W. Johnson is one of the world's most published scientists on the human effects of psychedelics, and has conducted seminal research in the behavioral economics of drug use, addiction, and risk behavior. Based on a thorough review of known risks of psychedelics, Dr. Johnson helped to resurrect psychedelic research by publishing psychedelic administration safety guidelines in 2008. He's also an advisor to Field Trip on the development of the novel synthetic psychedelic molecule, FT-104. Dr. Johnson joins Ronan to discuss his experience of conducting blind studies of psychoactive substances (including salvinorin A), his favorite new and classic psychedelic books, what makes a good trip guide, and more! Dr. Johnson is Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University.Please Follow Us:Field Trip Website - https://www.fieldtriphealth.comInstagram - @fieldtriphealthFacebook - @fieldtriphealthTwitter - @fieldtriphealthGuest Website: hopkinspsychedelic.org Twitter: @Drug_Researcher Feel free to leave Ronan a message with your comments, questions, or just to say hello! https://www.speakpipe.com/fieldtripping or write us an email at fieldtripping@kastmedia.com. And please check out our Field Tripping YouTube channel where you can watch the show!

La historia de los psicodélicos incluye visitas a México, ángeles y fugas de la cárcel. Pero las drogas psicodélicas no son solo fiesta, pues también ahora son usadas para salud mental y tratamiento de adicciones. Por eso hablamos con Matthew W. Johnson, Ph.D. de la Universidad Johns Hopkins quienes llevan la investigación más grande del mundo sobre este tema. La canción del intro es de Ferraz gracias a Sebastián Gutiérrez por el doblaje.

In this episode, Kyle and Joe interview Dr. Matthew Johnson: Professor at Johns Hopkins, writer of the recent paper, "Consciousness, Religion, and Gurus: Pitfalls of Psychedelic Medicine," and researcher (with others) on several trials through Johns Hopkins involving psilocybin: for smoking cessation, anorexia, mood and effects of early-stage Alzheimer's, opioid addiction, post-treatment Lyme disease syndrome, co-morbid alcoholism with depression, and soon, LSD for chronic pain.  Johnson talks about his paper, which largely deals with the ambiguity of the term "consciousness" and how it applies to David Chalmers' hard problem, and asks many philosophical questions: What is consciousness? What is phenomenal consciousness? Are things that seem like you actually similar? Do they have similar experiences or agency? How would you even know? If you built a robot that displays perfectly human-like qualities similar to yours and appears to have agency and experience, does it? Can you prove that it doesn't?  They also talk about how clinicians and investigators bringing their own religious and spiritual frameworks to psychedelic and breathwork sessions can create unnecessary expectations and narratives and make many people think the experience isn't for them, the theory that the default mode network decoupling just makes you feel not quite yourself and that this action can be observed with other non-psychedelic drugs, access consciousness, how it’s ok to feel things that can’t be proven scientifically, shamans, gurus, and the idea of enlightenment, the nuance in everything, and the beneficial sense of ownership people feel after getting through a challenging psychedelic session. Notable Quotes “It may very well be that the default mode network is a key or one of the keys that explains quintessential psychedelic effects, although it’s also possible that it’s not so special- that it explains maybe some of the effects sometimes, and that these aren’t so quintessentially psychedelic.”  “You don’t have to pretend like you have the answers. I don’t know, frankly, I think we’d all be better off if physicians had more humility. …There’s a whole lot about the human body we don’t know.”“Whether we’re talking about a Richard Dawkins style- you know, kind of a hard atheist who might be inclined to be of the spaghetti monster variety-appreciating person, or whether it be [a] Muslim- like, do we want a statue of a Buddha to tell either of those people that ‘this is not for you’ if they’re incredibly suffering from end-of-life anxiety, if they’re suffering from a decades-long addiction, if they’re depressed and are at risk of suicide? I don’t know, it just seems like we really need to think: how is this going to play out in the world and how are we really going to help people? Do we really want someone to think, ‘Oh no, this stuff is for hippies or new age folks’? They might be a political conservative, they might be a veteran, they might be someone who would never touch an illicit drug in their life. Do we want those types of people saying, ‘This is not for me’? I just see these as human experiences.” “One of the reasons why psychedelics and probably breathwork can be so effective is that people are doing their own heavy lifting. ...At least in the type of work that [I do in] clinical research with psychedelics, people come out feeling they have done (rightfully so) the heavy lifting. It’s not like, ‘Oh, I took some pill, and thanks to Pfizer, who was able to figure out a way to manipulate my serotonin system, I’m feeling better. Thanks to Doc So-and-so who knew that I needed Lexapro rather than Prozac.’ It’s like, ‘No, you faced your own demons, dude. You did the hard work. You cried your heart out about that thing you did you don’t feel good about and you came out with a laundry list of what you need to fix with your life, and with this renewed sense because you feel like you’ve earned it.’”   Links "Consciousness, Religion, and Gurus: Pitfalls of Psychedelic Medicine," by Matthew W. Johnson The Hard Problem of Consciousness explanation Hopkinspsychedelic.org Clinicaltrials.gov About Dr. Matthew Johnson Support the show Patreon Leave us a review on Facebook or iTunes Share us with your friends Join our Facebook group - Psychedelics Today group – Find the others and create community. Navigating Psychedelics  

Matthew W. Johnson is a professor and psychedelics researcher at Johns Hopkins. Please support this podcast by checking out our sponsors: – Brave: https://brave.com/lex – Neuro: https://www.getneuro.com and use code LEX to get 15% off – Four Sigmatic: https://foursigmatic.com/lex and use code LexPod to get up to 60% off – Cash App: https://cash.app/ and use code LexPodcast to get $10 EPISODE LINKS: Matt’s Twitter: https://twitter.com/Drug_Researcher Matt’s Website: https://www.hopkinsmedicine.org/profiles/results/directory/profile/0800020/matthew-johnson Study Website: https://hopkinspsychedelic.org/ PODCAST INFO: Podcast website: https://lexfridman.com/podcast Apple Podcasts: https://apple.co/2lwqZIr Spotify: https://spoti.fi/2nEwCF8 RSS: https://lexfridman.com/feed/podcast/ YouTube Full Episodes: https://youtube.com/lexfridman YouTube Clips: https://youtube.com/lexclips SUPPORT & CONNECT: – Check out the sponsors above, it’s

This week, Kate and Oliver are joined by Dr. Matthew Johnson, Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University, who is one of the world’s most published scientists on the human effects of psychedelics. They talk about his research and the potential of psilocybin to treat opioid dependence, PTSD, smoking addiction, cancer distress, and more.Executive Producers: Kate Hudson and Oliver HudsonProduced by Allison BresnickMusic by Mark HudsonThis show is powered by Simplecast.This episode is sponsored by Coors Light, Sakara (PROMO: SIBLINGEARLYACCESS), Honey, Article, and Helix.

In this interview, Don MacPherson is joined by Dr. Matthew Johnson, an expert in psychoactive drug effects, addiction, and risk behavior. They discuss clinical research on psychedelics including psilocybin, ayahuasca, DMT, MDMA, LSD, and more. They also dive into the potential therapeutic applications for psychedelics including treating depression, PTSD, and addiction, and improving individual happiness, creativity, and selflessness.Matthew W. Johnson, Ph.D., Professor at Johns Hopkins, is an expert in psychoactive drug effects, addiction, and risk behavior. He has worked with psychedelics since 2004. He developed and published the first psychedelic treatment of tobacco addiction in 2014. With colleagues, he conducted and published the largest study of psilocybin in cancer distress in 2016. He is Principal Investigator on upcoming psilocybin studies treating opioid addiction and PTSD, and LSD research treating chronic pain.

bengreenfieldfitness.com/psychedelics My guest on today's show, Dr. Matthew W. Johnson, Ph.D., is a professor of psychiatry and behavioral sciences at Johns Hopkins University.     He also happens to be one of the world’s most published scientists on the topic of the effects of psychedelics on humans and has conducted seminal research on the behavioral economics of drug use, addiction, and risk behavior.       The  will help provide the funds—$30 million total—needed to complete the studies required for FDA approval of MDMA-assisted psychotherapy for PTSD. MAPS has already raised $10 million. If another $10 million are raised by September 10th, this will unlock a $10 million challenge pledge that Tim Ferriss has helped put together, alongside PSFC. Half of the pledge comes from the  (), and the rest is split equally between Tim; James Bailey from Bail Capital; Peter Rahal, the founder of RXBAR (); Blake Mycoskie, the founder of TOMS (); and an anonymous donor. This challenge pledge is all or nothing. If MAPS fails to raise $10 million by September 10th, they do not receive the $10 million challenge pledge. There is no partial credit, and there is a real urgency. This $10M challenge pledge was announced in , the founder of . Every dollar matters, so if the spirit moves you, please consider giving what you can . If you can contribute $100,000 or more over two years, please get in touch with Rick and his team by emailing .         In this conversation with Dr. Matt Johnson, you'll discover:         -The major announcement made at Johns Hopkins regarding psychedelic research...14:15           -How to explain the efficacy of psychedelics to "healthy normal" people...19:00               -The gold standard on microdosing for enhanced productivity...23:05               -Matt's response to the suggestion that he's just in it for the drugs...32:40                 -How psychedelics are used to treat addiction to tobacco...38:35               -How to handle participants who experience anxiety during the session...53:07               -The dark side of MDMA and other psychedelics...1:04:30               Episode sponsors: Kion Aminos, Organifi Gold, Joovv, Water and Wellness         bengreenfieldfitness.com/psychedelics

Are There Mental Health Benefits of MDMA?Mainstream Mental Health Radio with Dr. John HuberGUEST: Matthew W. Johnson, Ph.D. MDMA which is commonly known as ecstasy may have a much greater purpose beyond being an important aspect of rave events nationwide. Our guest today on Mainstream Mental Health radio is Matthew Wayne Johnson, Ph.D., Associate Professor of Psychiatry and Behavioral Sciences at Johns Hopkins Bayview Campus. Dr. Johnson has studied the therapeutic effects of the psychedelic compound psilocybin in the treatment of addiction, and in the treatment of cancer-related anxiety and depression. He has also studied Psychopharmacology of psilocybin, salvinorin A, and other psychedelics/hallucinogens. WEBSITE OF INTEREST - http://psychedelicscience.org/conference Dr. Johnson based on your research, do you think that MDMA provides any medicinal purpose in treating people with mental health disorders?How does MDMA affect the brain and basic cognitive function?   How can Post Traumatic Stress be perceived on MDMA and can MDMA cause a person to have a permanent shift in perception on their PTSD?Why do you think that MDMA and other psychedelics are being slowly embraced by the medical community as legitimate means of treatment?Do you think that there is a danger of using MDMA as a form of treatment – as the individual could become addicted to it?How would you compare regulated MDMA to anti-depressants in terms of their short term and long term effectiveness or harm? 

Support Voiceclub on Patreon @ https://www.patreon.com/voiceclub Watch this episode @ https://youtu.be/H9pZOquAAyw --- This is a conversation about the relationship between psychedelic experience, mental health, society, the prominent role of the mystical experience in positive outcomes, and more - charted through the lens of one of the field's leading research scientists, Dr. Matthew Johnson. --- This is the first in a series of conversations which took place at Beyond Psychedelics in Prague, June 2018. The aim of the conference can be stated as follows: ‘To provide a platform for global cooperation among people with a professional interest in psychedelics. We aspire to facilitate the exchange of both scientific knowledge and real practical experience – at a global level and across a variety of disciplines, thus creating new synergies.’ Voiceclub is not affiliated with Beyond Psychedelics. Conversation Waypoints @ https://www.voiceclub.com/e14-psychedelics-consciousness-and-change-with-dr-matthew-johnson About the guests: Dr. Matthew W. Johnson Matthew W. Johnson, Ph.D., Associate Professor of Psychiatry at Johns Hopkins University School of Medicine, is a leading expert on the effects of psychedelics. He is an experimental psychologist with expertise on psychoactive drugs and the psychology of addiction and risk behavior. Matt has received >8 million US dollars in research funding as principal investigator from the US National Institutes of Health and non-profit foundations. For 20 years he has conducted academic research in psychopharmacology and addictions, and for 14 years he has conducted human research with psychedelics. Matthew Johnson at Johns Hopkins: https://www.hopkinsmedicine.org/profiles/results/directory/profile/0800020/matthew-johnson Matthew Johnson on Researchgate: https://www.researchgate.net/profile/Matthew_Johnson14 Melissa Warner Melissa is co-founder of The Australian Psychedelic Society and board member of PRISM (Psychedelic Research in Science and Medicine). She is a commentator on the science and philosophy of psychedelic substances on radio, print and online. Melissa holds a BSc in Neuroscience with a minor in computer programming. She is an avid meditator, yogi, performance artist, bio-hacker, and futurist. Her intellectual focus is currently the development of tools and frameworks to facilitate creative output, personal healing, and self-actualization. A survivor of complex PTSD, she lives as a case study for the efficacy of psychedelics as therapeutic tools. Melissa on Twitter: https://twitter.com/neuronymph_ PRISM: https://www.prism.org.au/ The Australian Psychedelic Society: https://www.facebook.com/AustralianPsychedelicSociety/ --- Support ---- Support Voiceclub on Patreon @ https://www.patreon.com/voiceclub Leave a review on Apple Podcasts @ https://www.itunes.apple.com/au/podcast/voice…d1271039497?mt=2 Or, share this content somewhere worthwhile. Follow Voiceclub on Twitter @ https://twitter.com/voiceclub_ Follow Voiceclub on Facebook @ https://www.facebook.com/voiceclub.podcast/ Tim Adalin @ www.instagram.com/tim_adalin/ Subscribe on Stitcher @ www.stitcher.com/podcast/voiceclub on Apple Podcasts @ itunes.apple.com/au/podcast/voice…d1271039497?mt=2 RSS @ feeds.soundcloud.com/users/soundclo…083/sounds.rss To the Voiceclub mailing list for exclusive content Subscribe to the podcast: on Stitcher @ https://www.stitcher.com/podcast/voiceclub on Apple Podcasts @ https://itunes.apple.com/au/podcast/voiceclub/id1271039497?mt=2 RSS @ http://feeds.soundcloud.com/users/soundcloud:users:242880083/sounds.rss Social: facebook.com/voiceclub.podcast/ twitter.com/voiceclub_ --- Music: Ours Samplus - Spell On You www.youtube.com/watch?v=V4ypU_3e_3E

Mainstream Mental Health Radio with Dr. John HuberGUEST: Matthew W. Johnson, Ph.D. MDMA which is commonly known as ecstasy may have a much greater purpose beyond being an important aspect of rave events nationwide. Our guest today on Mainstream Mental Health radio is Matthew Wayne Johnson, Ph.D., Associate Professor of Psychiatry and Behavioral Sciences at Johns Hopkins Bayview Campus. Dr. Johnson has studied the therapeutic effects of the psychedelic compound psilocybin in the treatment of addiction, and in the treatment of cancer-related anxiety and depression. He has also studied Psychopharmacology of psilocybin, salvinorin A, and other psychedelics/hallucinogens. WEBSITE OF INTEREST - http://psychedelicscience.org/conference Dr. Johnson based on your research, do you think that MDMA provides any medicinal purpose in treating people with mental health disorders?How does MDMA affect the brain and basic cognitive function?   How can Post Traumatic Stress be perceived on MDMA and can MDMA cause a person to have a permanent shift in perception on their PTSD?Why do you think that MDMA and other psychedelics are being slowly embraced by the medical community as legitimate means of treatment?Do you think that there is a danger of using MDMA as a form of treatment – as the individual could become addicted to it?How would you compare regulated MDMA to anti-depressants in terms of their short term and long term effectiveness or harm?